Why it matters: Bubs’ sales in China slowed further in the fourth quarter.
It has axed its relationship with China distributor AZ Global.
With new trade partners, Bubs expects China sales to “build steadily”.
Infant formula company Bubs’ China sales deteriorated further over the past quarter as excess stock and an ongoing dispute with its biggest daigou partner, AZ Global, dented demand.
Bubs Australia’s full-year revenue slid 29 per cent to $73.7 million.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
